Outcomes-based contracting in the US pharmaceutical market
Slides in the pack:
- An introduction to outcomes-based contracting
- Payers are looking for outcomes-based contracting in various therapeutic areas
- History of outcomes-based contracting in the US
- Outcomes-based contracts recently announced in the US
- In 2015, Amgen negotiated its first pay-for-performance deal with Harvard Pilgrim for Repatha
- In 2017, Amgen negotiated another outcomes-based contract with Harvard Pilgrim for Enbrel
- Types of pharmaceutical outcomes-based contracts
- Pre-conditions for the implementation of outcomes-based contracts
- Benefits and challenges associated with outcomes-based contracts
Reviews
There are no reviews yet.